Genetic Technologies Stock Return On Equity
GENEDelisted Stock | USD 0.77 0.00 0.00% |
Genetic Technologies fundamentals help investors to digest information that contributes to Genetic Technologies' financial success or failures. It also enables traders to predict the movement of Genetic Stock. The fundamental analysis module provides a way to measure Genetic Technologies' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Genetic Technologies stock.
Genetic |
Genetic Technologies Company Return On Equity Analysis
Genetic Technologies' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Genetic Technologies Return On Equity | -1.85 |
Most of Genetic Technologies' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Genetic Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Genetic Technologies has a Return On Equity of -1.8498. This is 92.28% lower than that of the Life Sciences Tools & Services sector and 72.31% lower than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.
Genetic Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Genetic Technologies' direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Genetic Technologies could also be used in its relative valuation, which is a method of valuing Genetic Technologies by comparing valuation metrics of similar companies.Genetic Technologies is currently under evaluation in return on equity category among its peers.
Genetic Fundamentals
Return On Equity | -1.85 | ||||
Return On Asset | -0.63 | ||||
Profit Margin | (1.24) % | ||||
Operating Margin | (1.13) % | ||||
Current Valuation | 3.44 M | ||||
Shares Outstanding | 4.85 M | ||||
Shares Owned By Institutions | 1.87 % | ||||
Number Of Shares Shorted | 25.84 K | ||||
Price To Earning | (1.87) X | ||||
Price To Book | 3.25 X | ||||
Price To Sales | 0.38 X | ||||
Revenue | 7.66 M | ||||
Gross Profit | 6.01 M | ||||
EBITDA | (11.43 M) | ||||
Net Income | (12.02 M) | ||||
Cash And Equivalents | 11.74 M | ||||
Cash Per Share | 0.76 X | ||||
Total Debt | 875.19 K | ||||
Debt To Equity | 0.04 % | ||||
Current Ratio | 3.86 X | ||||
Book Value Per Share | 0.01 X | ||||
Cash Flow From Operations | (9.68 M) | ||||
Short Ratio | 15.67 X | ||||
Earnings Per Share | (0.02) X | ||||
Target Price | 12.5 | ||||
Number Of Employees | 55 | ||||
Beta | 0.48 | ||||
Market Capitalization | 3.71 M | ||||
Total Asset | 6.19 M | ||||
Retained Earnings | (166.38 M) | ||||
Working Capital | (500.09 K) | ||||
Current Asset | 9.03 M | ||||
Current Liabilities | 992 K | ||||
Net Asset | 6.19 M |
About Genetic Technologies Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Genetic Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Genetic Technologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Genetic Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.BTC | Bitcoin | |
TRX | TRON | |
BNB | Binance Coin |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Consideration for investing in Genetic Stock
If you are still planning to invest in Genetic Technologies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Genetic Technologies' history and understand the potential risks before investing.
Stocks Directory Find actively traded stocks across global markets | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum |